GgoogleIT first seen 1 d ago, last 1 d ago, peak #4

FDA Clears Pivotal Trial for Chronic Ischemic Stroke Device

Original: ischemia

NeuWire Medical has received FDA investigational device exemption approval to launch its STROKE-REWIRE pivotal study targeting chronic ischemic stroke. The approval allows the company to begin a large-scale clinical trial of its device in patients with long-standing stroke-related disability. Medical observers are watching the study as a potential new option for a patient group with limited current treatments.

Why now: The FDA approval of a new pivotal trial for chronic ischemic stroke is fresh news of interest to the stroke treatment community.

NeuWire MedicalFDASTROKE-REWIRE

Open on google →

Rank over time, top of the chart is #1. 2 snapshots from 1 d ago to 1 d ago.

Evidence

• NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke · Business Wire

API: https://socialmediatrends-api.osmike.com/v1/trends/1528313